Johnson & Johnson: Dermatitis, Atopic trials

The registry lists 24 Dermatitis, Atopic studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 10 have results posted.

Early Phase 1 1Phase 1 2Phase 2 10Phase 4 2No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic DermatitisTerminatedNCT04990440Phase 2Results posted
• A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic DermatitisTerminatedNCT04791319Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic DermatitisCompletedNCT04021862Phase 2Results posted
• A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic DermatitisCompletedNCT03496974Phase 2Results posted
• Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With EczemaCompletedNCT02691507Phase 2Results posted
• Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With EczemaCompletedNCT02357940Not applicableResults posted
• A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic DermatitisCompletedNCT01945086Phase 2Results posted
• Human Testing of an Over-the-Counter (OTC) Cream in Children With EczemaCompletedNCT01326910Not applicableResults posted
• To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in ChildrenCompletedNCT00886587Not applicableResults posted
• An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic DermatitisTerminatedNCT00455429Phase 2Results posted
• A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic DermatitisActive, not recruitingNCT07230860Phase 2
• A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)TerminatedNCT06881251Phase 2
• Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)TerminatedNCT05859724Phase 1
• A Study of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin AreaCompletedNCT05226143Not applicable
• A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin ParticipantsCompletedNCT05094700Not applicable
• A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion in Adults of Atopic Dermatitis.CompletedNCT05062213Not applicable
• A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion and a Lip Moisturizer in Adults of Atopic Dermatitis.WithdrawnNCT04950374Not applicable
• A Study of a Moisturizing Cream and Baby Wash in the Management of Mild to Moderate Atopic Dermatitis in Infants, Toddlers and ChildrenCompletedNCT04740892Not applicable
• A Study of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic DermatitisCompletedNCT04662619Not applicable
• A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic DermatitisCompletedNCT02345928Phase 1
• A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy ParticipantsCompletedNCT02343783Early Phase 1
• An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic DermatitisCompletedNCT01828879Phase 4
• An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic DermatitisCompletedNCT01782729Phase 4
• A Study of JNJ-39758979 in Adult Japanese Patients With Moderate Atopic DermatitisTerminatedNCT01497119Phase 2